Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 2, 2015, Pages 191-199

  Jabaudon, Matthieu ^a,b   Blondonnet, Raiko ^a,b   Roszyk, Laurence ^a,b   Bouvier, Damien ^a,b   Audard, Jules ^a   Clairefond, Gael ^b   Fournier, Mathilde ^a   Marceau, Geoffroy ^a,b   Déchelotte, Pierre ^a   Pereira, Bruno ^a   Sapin, Vincent ^a,b   Constantin, Jean Michel ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Acid aspiration; Alveolar epithelium; Animal model; Lung injury resolution; Pulmonary edema

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; INTERLEUKIN 17; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BIOLOGICAL MARKER; CYTOKINE; IMMUNOGLOBULIN RECEPTOR;

ACID ASPIRATION; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALBUMIN BLOOD LEVEL; ALVEOLAR FLUID CLEARANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FRACTION OF INSPIRED OXYGEN; GAS ANALYSIS PARAMETERS; HISTOLOGY; HUMAN; INJURY SEVERITY; LUNG DIFFUSION; LUNG EXAMINATION; LUNG FLUID; LUNG INJURY; MALE; MIDDLE AGED; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBSERVATIONAL STUDY; OXYGEN TENSION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THICKNESS; TIDAL VOLUME; TISSUE STRUCTURE; UPREGULATION; ANIMAL; BLOOD; DISEASE MODEL; LUNG; LUNG ALVEOLUS; LUNG LAVAGE; PATHOPHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG; MALE; MICE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY ALVEOLI; RECEPTORS, IMMUNOLOGIC; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84938125364     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201501-0020OC     Document Type: Article

References (45)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693.
2. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand J-A, Villar J, Thorsteinsson A, et al.; ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 2004;30:51-61.
3. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163: 1376-1383.
4. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
5. Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal J-M, Perez D, Seghboyan J-M, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-1116.
6. Guérin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, et al.; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159-2168.
7. 2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011;184:561-568.
8. Matthay MA. Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med 2014;189:1301-1308.
9. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003;167: 1027-1035.
10. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation endproducts is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006;173:1008-1015.
11. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA; NHLBI ARDS Network. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008;63:1083-1089.
12. Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier C, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 2011;39:480-488.
13. Patel BV, Wilson MR, Takata M. Resolution of acute lung injury and inflammation: a translational mouse model. Eur Respir J 2012;39:1162-1170.
14. Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009;135:269-275.
15. Patel BV, Wilson MR, O'Dea KP, Takata M. TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury. J Immunol 2013;190:4274-4282.
16. Blondonnet R, Jabaudon M, Clairefond G, Audard J, Sapin V, Constantin J-M. Corrélation entre clairance liquidienne alvéolaire et sRAGE plasmatique dans un modèle murin de syndrome de détresse respiratoire aiguë (SDRA) par instillation d'acide chlorhydrique [abstract]. Ann Fr Anesth Reanim 2014;33:A137.
17. Blondonnet R, Jabaudon M, Clairefond G, Audard J, Bouvier D, Marceau G, Blanc P, Dechelotte P, Sapin V, Constantin J-M. Elevated levels of soluble rage predict impaired alveolar fluid clearance in a translational mouse model of acute respiratory distress syndrome (ARDS) [abstract]. Intensive Care Med Exp 2014;2:P62.
18. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM; Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011;44:725-738.
19. Ogawa EN, Ishizaka A, Tasaka S, Koh H, Ueno H, Amaya F, Ebina M, Yamada S, Funakoshi Y, Soejima J, et al. Contribution of highmobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit Care Med 2006;174:400-407.
20. Aeffner F, Traylor ZP, Yu ENZ, Davis IC. Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice. Am J Physiol Lung Cell Mol Physiol 2011;301:L99-L109.
21. Wolk KE, Lazarowski ER, Traylor ZP, Yu ENZ, Jewell NA, Durbin RK, Durbin JE, Davis IC. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med 2008;178:969-976.
22. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990;142:1250-1257.
23. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307: 2526-2533.
24. Constantin J-M, Cayot-Constantin S, Roszyk L, Futier E, Sapin V, Dastugue B, Bazin J-E, Rouby J-J. Response to recruitment maneuver influences net alveolar fluid clearance in acute respiratory distress syndrome. Anesthesiology 2007;106:944-951.
25. Puybasset L, Cluzel P, Gusman P, Grenier P, Preteux F, Rouby JJ; CT Scan ARDS Study Group. Regional distribution of gas and tissue in acute respiratory distress syndrome. I. Consequences for lung morphology. Intensive Care Med 2000;26:857-869.
26. Berthiaume Y, Staub NC, Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 1987;79:335-343.
27. Zhang F, Nielsen LD, Lucas JJ, Mason RJ. Transforming growth factor-β antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor. Am J Respir Cell Mol Biol 2004;31:679-686.
28. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-L399.
29. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012;11:763-776.
30. D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, Pipeling MR, Brower RG, Tuder RM, McDyer JF, et al. CD41CD251Foxp31 Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 2009; 119:2898-2913.
31. Voelker MT, Fichtner F, Kasper M, Kamprad M, Sack U, Kaisers UX, Laudi S. Characterization of a double-hit murine model of acute respiratory distress syndrome. Clin Exp Pharmacol Physiol 2014;41:844-853.
32. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004;170:766-772.
33. Christie JD, Robinson N, Ware LB, Plotnick M, De Andrade J, Lama V, Milstone A, Orens J, Weinacker A, Demissie E, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007;175:69-74.
34. Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, et al.; Lung Transplant Outcomes Group. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009;180:1010-1015.
35. Li J, Qu X, Schmidt AM. Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J Biol Chem 1998;273:30870-30878.
36. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-25761.
37. Fehrenbach H, Weiskirchen R, Kasper M, Gressner AM. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 2001;34:943-952.
38. Downs CA, Kreiner LH, Johnson NM, Brown LA, Helms MN. Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels. Am J Respir Cell Mol Biol 2015;52:75-87.
39. Su X, Looney MR, Gupta N, Matthay MA. Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am J Physiol Lung Cell Mol Physiol 2009;297:L1-L5.
40. Walter JM, Wilson J, Ware LB. Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care. Expert Rev Respir Med 2014;8:573-586.
41. Constantin J-M, Grasso S, Chanques G, Aufort S, Futier E, Sebbane M, Jung B, Gallix B, Bazin JE, Rouby J-J, et al. Lung morphology predicts response to recruitment maneuver in patients with acute respiratory distress syndrome. Crit Care Med 2010;38:1108-1117.
42. Yu ENZ, Traylor ZP, Davis IC. Effect of ventilation pressure on alveolar fluid clearance and beta-agonist responses in mice. Am J Physiol Lung Cell Mol Physiol 2009;297:L785-L793.
43. Watkins TR. The monocyte and acute respiratory distress syndrome: implicated, innocent bystander, or awash in research translation? Am J Respir Crit Care Med 2013;188:407-408.
44. Drake AC. Of mice and men: what rodent models don't tell us. Cell Mol Immunol 2013;10:284-285.
45. Matthay MA, Howard JP. Progress in modelling acute lung injury in a pre-clinical mouse model. Eur Respir J 2012;39:1062-1063.